AI assistant
Syncom Formulations (India) Ltd. — Capital/Financing Update 2026
May 4, 2026
60987_rns_2026-05-04_b5177e57-92b3-433e-9379-a36ba535d870.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
SYNCOM
SYNCOM
FORMULATIONS (INDIA) LIMITED
A WHO-GMP & ISO 9001:2015 Certified Company
CIN No.: L24239MH1988PLC047759
Regd. Off.: 7, Niraj Industrial Estate, Off Mahakali Caves Road, Andheri (East), Mumbai - 400 093, INDIA, Tel.: +91-22-42824400, Email: [email protected]
Corp. Off.: 207, Saket Nagar, Indore - 452 018, INDIA, Tel.: +91-731-2560458 / 2700458, Email: [email protected], Website: www.sfil.in
Works: 256-257, Sector-I, Pithampur, Dist.-Dhar, M.P. - 454 775, INDIA, Tel.: +91-7292-403122 / 407039, Email: [email protected]
SYNCOM/SE/2026-27
4th May, 2026
Online filing at: www.listing.bseindia.com and https://neaps.nseindia.com/NEWLISTINGCORP/login.jsp
To,
BSE Limited
Phiroze Jeejeebhoy Tower,
Dalal Street,
Mumbai (M.H.) 400 001
BSE CODE:524470
To,
National Stock Exchange of India Limited
Exchange Plaza, C-1, Block G,
Bandra Kurla Complex, Bandra (E),
Mumbai- 400051
NSE SYMBOL: SYNCOMF
Sub: Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 read with Master SEBI Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026.
Dear Sir/Ma’am,
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with the SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026, we hereby inform the Exchange that the company's bid for the acquisition of a commercial property has been accepted by HDFC Bank Ltd., which is material in nature.
Further, the company has successfully completed the purchase of the entire 7th Floor, Trade Star, Andheri-Kurla Road, Andheri (E), Mumbai-400059.
In this regard, the company has paid a total consideration of Rs. 57,26,00,000/- (Rupees Fifty-Seven Crore Twenty Six Lacs Only) to HDFC Bank Ltd towards the full and final consideration for the said acquisition.
You are requested to kindly take the above information on record and disseminate it on the website of BSE/NSE.
Thanking You,
Yours Faithfully,
For, SYNCOM FORMULATIONS (INDIA) LIMITED
Vaishali
Agrawal
Digitally signed by
VISHALAI Agrawal
CSE VISHALI AGRAWAL
COMPANY SECRETARY &
COMPLIANCE OFFICE
CRATUS EVOLVE
CRATUS Optima
CRATUS ICURA
Intensive Care Redefined
CRATUS
Arenal Healthcare
CRATUS
RIGHT NUTRITION
www.cratsscant.com
SYNCOM
MOBILIO